Yiviva signed MOU with AstraZeneca to establish research, development collab

Yiviva signed a memorandum of understanding, MOU, with AstraZeneca China to establish a research and development collaboration, collab, at AstraZeneca’s Innovation Campus in Chengdu, China. The signing ceremony took place at the 2023 China International Import Expo at the National Exhibition and Convention Center in Shanghai. To address global unmet medical needs, Together Yiviva and AstraZeneca China will jointly build platforms for scientific research transformation and industrial development led by academicians and experts with the aim to modernize botanical medicines in accordance with new regulatory pathways for botanical medicines by the United States Food and Drug Administration and China National Medical Products Administration.